Latest Articles
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …
Published: Feb. 3, 2026, 1 p.m.
How Patients Define Treatment Options in Endometrial Cancer Trials - Medscape
How Patients Define Treatment Options in Endometrial Cancer Trials Medscape
Published: Feb. 2, 2026, 7:08 p.m.
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN - Dove Medical Press
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived | IJN Dove Medical Press
Published: Feb. 2, 2026, 7:47 a.m.
Sildenafil Citrate as a Modulator of Endometrial Receptivity in Assisted Reproductive Technologies - viagra8ordernow.com
Sildenafil Citrate as a Modulator of Endometrial Receptivity in Assisted Reproductive Technologies viagra8ordernow.com
Published: Feb. 2, 2026, 2:22 a.m.
Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan - Oncodaily
Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan Oncodaily
Published: Feb. 1, 2026, 4:57 a.m.
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study - Frontiers
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study Frontiers
Published: Jan. 30, 2026, 6:10 p.m.
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings - Oncodaily
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings Oncodaily
Published: Jan. 30, 2026, 5:27 p.m.
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction - Quiver Quantitative
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction Quiver Quantitative
Published: Jan. 29, 2026, 1:31 p.m.
Endometrial Ablation Market Size, Share, Growth | CAGR of 5.3% - Market.us
Endometrial Ablation Market Size, Share, Growth | CAGR of 5.3% Market.us
Published: Jan. 29, 2026, 12:11 p.m.
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - targetedonc.com
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment targetedonc.com
Published: Jan. 28, 2026, 10:02 p.m.
Link copied to clipboard!